GSK · 4 months ago
Director, Emerging Diagnostic Technologies
USA - Pennsylvania - Upper Providence
Full-time
Onsite
Director/Executive
7+ years expGSK is a global biopharma company dedicated to advancing healthcare through innovation. They are seeking a Director of Emerging Diagnostic Technologies to lead the development of cutting-edge diagnostic platforms and strategies in oncology, focusing on biomarker discovery and clinical development. The role involves collaboration with cross-functional teams to drive innovation and enhance patient outcomes in cancer treatment.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Lead innovation in emerging diagnostic technologies, including ctDNA, computational pathology, advanced imaging techniques, and multi-modal biomarker platforms, to enhance patient stratification, therapeutic targeting, and mechanism-of-action insights
Develop and apply oncology foundational models and AI/ML analytical approaches to complex clinical, real-world and biomarker datasets, including high-dimensional data such as single-cell transcriptomics, spatial omics, proteomics, and cfDNA
Serve as a subject matter expert in application of analytical methods and emerging diagnostic technologies to enable biomarker discovery and diagnostic strategies to optimize patient selection, dose determination, and combination therapy approaches with a focus on antibody-drug conjugates (ADCs)
Oversee the integration of oncology foundational models to inform translational medicine and clinical development strategies ensuring robust interpretation, practical implementation and timely communication across matrix teams
Collaborate with cross-functional teams, clinical development, CPMS (Clinical Pharmacology and Modeling Simulation), Diagnostic, Translational Research, and AI/ML teams, to evaluate and apply complementary data analytics approaches for meaningful insights into complex biology
Lead efforts to identify, evaluate, and implement emerging technology platforms to advance diagnostic innovation and support pipeline growth
Provide leadership and accountability for clear and timely communication of data analysis outputs, complex analytical principles, and models to diverse stakeholders, including senior leaders and non-technical partners
Champion the integration of biomarker and diagnostic strategies into clinical development plans, ensuring alignment with oncology research unit and translational medicine objectives
Drive the application of computational pathology and AI-driven image analysis to enhance diagnostic capabilities and biomarker discovery in oncology programs
Support the evaluation of academic partnerships and external technology platforms, ensuring alignment with Oncology Translational Medicine goals and innovation priorities
Contribute to due diligence efforts for business development opportunities, leveraging expertise in advanced analytics and emerging diagnostic technologies
Qualification
Required
PhD degree or equivalent experience/training in computational biology, bioinformatics, machine learning, computational pathology, or a related field
7+ years of applied experience in Pharma/Biotech or an academic setting, with a focus on oncology research, diagnostic innovation, and biomarker analysis
Demonstrated ability to lead and influence cross-functional teams in a matrix environment, driving alignment and delivering impactful outcomes
Experience with emerging diagnostic platforms and technologies, including their application to translational medicine and clinical development
Demonstrated advanced knowledge of statistical and analytical methods relevant to the analysis of complex high-dimensional heterogeneous datasets
Experience with GitHub, development of R Shiny applications/R markdown, and working in cloud or high-performance computing (HPC) environments
Preferred
MD degree with oncology clinical development experience is highly desirable and considered an upside for this role
Expertise in oncology foundational models and AI/ML analytical approaches applied to complex biomarker datasets
Proficiency in coding skills (e.g., R, Python) and strong working knowledge of bioinformatics databases, resources, and tools
Proven ability to analyze and interpret high-dimensional datasets (e.g., single-cell and spatial transcriptomics, proteomics, cfDNA) using advanced modeling techniques
Experience with computational pathology and AI-driven image analysis in the context of diagnostic innovation
Strong knowledge of clinical trial biomarker data analysis and its application to precision medicine strategies
Demonstrated experience with antibody-drug conjugates (ADCs) and their associated biomarker and diagnostic strategies
Proven leadership experience in driving diagnostic innovation and implementing emerging technologies in oncology research
Strong track record of integrating preclinical and clinical biomarker data to inform translational medicine strategies
Familiarity with regulatory requirements and data standards for transitioning programs into clinical trials
Strategic mindset with the ability to influence and drive decision-making in a matrix environment
Company
GSK
We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia
10001+ employees
H1B Sponsorship
GSK has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (45)
2024 (56)
2023 (54)
2022 (53)
2021 (54)
2020 (72)
Funding
Current Stage
Public CompanyTotal Funding
$25.51MKey Investors
CARB-X
2021-03-02Grant· $18M
2020-09-23Grant· $7.51M
1978-01-13IPO
Leadership Team
Julie Brown
CFO
Mike Elmore
SVP & Chief Information Security Officer, GSK
Recent News
South China Morning Post
2026-01-08
2026-01-07
Company data provided by crunchbase